Search clinical trials for: DAS181-F02 formulation
Total 2363 results
-
AllerganCompleted
-
Amicus TherapeuticsActive, not recruiting
-
University of British ColumbiaUnknownCicatrix | Scar | Keloid | Hypertrophic Scar | Skin Graft Scar | Skin Graft Complications | Donor Site ComplicationCanada
-
Lipidor ABBioskin GmbHCompleted
-
GlaxoSmithKlineCompletedHealthy VolunteerUnited Kingdom
-
MedicagoWithdrawn
-
IpsenCompletedAcromegalyFrance, Switzerland
-
University of MalayaMerck Serono International SATerminatedNasopharyngeal CarcinomaMalaysia
-
Grupo de Investigacao do Cancro DigestivoUnknownColorectal CarcinomaPortugal
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); ICESActive, not recruitingKidney Diseases | Hemodialysis | End-Stage Kidney DiseaseCanada
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
CinDome Pharma, Inc.Terminated
-
Pennine Acute Hospitals NHS TrustUnknown
-
IpsenCompleted
-
IpsenCompleted
-
Eli Lilly and CompanyCompletedAdvanced CancerPuerto Rico, United States
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedColorectal NeoplasmsUnited States
-
Ultragenyx Pharmaceutical IncNot yet recruitingAngelman SyndromeUnited States, Australia, Canada, Germany, United Kingdom, Israel, France, Spain
-
Verve Therapeutics, Inc.Not yet recruitingHeterozygous Familial Hypercholesterolemia | Premature Coronary Heart Disease
-
REGENXBIO Inc.RecruitingDuchenne Muscular DystrophyUnited States
-
J Ints BioRecruitingEGFR Mutant Advanced Non-small Cell Lung CancerKorea, Republic of, United States, Thailand
-
Cue BiopharmaRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian CancerUnited States
-
Aegle TherapeuticsCongressionally Directed Medical Research ProgramsRecruiting
-
Chong Kun Dang PharmaceuticalSamsung Medical Center; Asan Medical Center; Seoul National University HospitalRecruiting
-
Aegle TherapeuticsNot yet recruitingDystrophic Epidermolysis Bullosa
-
ImmuneOncia Therapeutics Inc.CompletedLymphoma | Solid TumorKorea, Republic of, United States
-
Alpine Immune Sciences, Inc.TerminatedLymphoma | Advanced Solid TumorUnited States, Australia
-
UNEEG Medical A/STerminated
-
Kyowa Kirin Co., Ltd.TerminatedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
GenSpera, Inc.CompletedAdvanced Solid TumorsUnited States
-
Neothetics, IncUnknown
-
Threshold PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | High-risk Myelodysplastic Syndrome | Advanced MyelofibrosisUnited States
-
Baylor College of MedicineHarris County Hospital District; The Methodist Hospital Research InstituteWithdrawn
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.CompletedSolid Tumors | Lymphoid MalignanciesUnited States
-
Xigen SACompleted
-
IpsenCompletedCarcinoma | Peritoneal Neoplasms | Intestinal ObstructionFrance, Netherlands, Belgium
-
Stanford UniversityCompleted
-
Boston Children's HospitalCompleted
-
Centre Oscar LambretUnknownEpidermoid Head and Neck CancerFrance
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHealthy VolunteersUnited States
-
University of FloridaGlaxoSmithKline; Food and Drug Administration (FDA)CompletedHypersensitivityUnited States
-
Oslo University HospitalUniversity of OsloRecruiting
-
AllerganCompletedIdiopathic Eyelash HypotrichosisRussian Federation, Sweden, United States, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono GmbH, GermanyCompletedInfertility | Ovulation Induction
-
TOLREMO therapeutics AGRecruitingCancer | Adult Solid Tumor | Advanced Solid Tumor | Adult DiseaseSpain, Switzerland
-
Frontera TherapeuticsPeking Union Medical College Hospital; Eye & ENT Hospital of Fudan University; Henan Provincial People's HospitalRecruitingX-Linked Retinitis PigmentosaChina
-
ImmuneOncia Therapeutics Inc.RecruitingAdvanced CancerKorea, Republic of
-
Da Zen Theranostics IncRecruitingLymphoma | Solid TumorUnited States